Tag: Bempegaldesleukin

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Bempegaldesleukin

Nektar Therapeutics (NASDAQ:NKTR) CAO Jillian B. Thomsen Sells 2713 Shares

Added to Collection on: 2019-12-15 13:26:15

Tags for this article:

Financial markets
Finance
Nektar Therapeutics
Financial economics
Bempegaldesleukin
Price?earnings ratio
Stock

Click the tags to see associated articles and topics

View Article Details
Nektar Therapeutics (NASDAQ:NKTR) Upgraded to Hold by BidaskClub

Added to Collection on: 2019-12-18 09:18:45

Tags for this article:

Financial markets
Stock market
Equity securities
Finance
Financial economics
Nektar Therapeutics
Stock
Price?earnings ratio
Bempegaldesleukin
Share

Click the tags to see associated articles and topics

View Article Details
Investors Purchase High Volume of Put Options on Nektar Therapeutics (NASDAQ:NKTR)

Added to Collection on: 2019-12-04 14:00:00

Tags for this article:

Financial markets
Equity securities
Stock market
Finance
Financial economics
Nektar Therapeutics
Bempegaldesleukin
Share
Stock
Price?earnings ratio

Click the tags to see associated articles and topics

View Article Details
Metropolitan Life Insurance Co NY Sells 5967 Shares of Nektar Therapeutics (NASDAQ:NKTR)

Added to Collection on: 2020-01-03 13:33:58

Tags for this article:

Financial markets
Equity securities
Stock market
Finance
Financial economics
Nektar Therapeutics
Bempegaldesleukin
Price?earnings ratio
Stock
Nektar
Share
METROPOLITAN LIFE INSURANCE CO NY

Click the tags to see associated articles and topics

View Article Details
Private Asset Management Inc. Takes Position in Nektar Therapeutics (NASDAQ:NKTR)

Added to Collection on: 2020-01-03 19:31:25

Tags for this article:

Financial markets
Finance
Nektar Therapeutics
Financial economics
Bempegaldesleukin
Price?earnings ratio
Stock
Private Asset Management Inc

Click the tags to see associated articles and topics

View Article Details
ImaginAb Announces License and Supply Agreement with Pfizer for CD8 ImmunoPET Technology

Added to Collection on: 2021-01-07 02:37:30

Tags for this article:

Medical specialties
Medicine
Clinical medicine
Immunology
T cells
Pfizer
Clusters of differentiation
Positron emission tomography
Cancer immunotherapy
Cytotoxic T cell
Immunotherapy
Bempegaldesleukin
ImaginAb Inc.

Click the tags to see associated articles and topics

View Article Details
OncoSec Appoints Bridget O'Keeffe, Ph.D. as Vice President of Clinical Development

Added to Collection on: 2021-02-18 13:30:00

Tags for this article:

Clinical medicine
Medicine
Cancer treatments
Cancer immunotherapy
Antineoplastic drugs
Immunology
Interleukin 2
Interleukins
Bempegaldesleukin
Tumor microenvironment
Immunotherapy
Electroporation
Oncosec Medical Incorporated
Bridget O'Keeffe

Click the tags to see associated articles and topics

View Article Details
Nektar Therapeutics (NASDAQ:NKTR) Director Sells $151840.00 in Stock

Added to Collection on: 2021-04-17 23:37:30

Tags for this article:

Bempegaldesleukin
Nektar Therapeutics
Dividend
Short
Stock market
Financial markets
Financial economics

Click the tags to see associated articles and topics

View Article Details
NK Cell Therapy Pipeline, FDA Approvals, Clinical Trials Development, Companies 2023

Added to Collection on: 2023-12-04 21:46:32

Tags for this article:

Biotechnology
Genetic engineering
Bempegaldesleukin
NK-92
Pharmacy
Atlas Venture
Regenerative Medicine Advanced Therapy

Click the tags to see associated articles and topics

View Article Details
NK Cell Therapy Pipeline Outlook, Clinical Trials, FDA Approvals, and Companies 2024 (Updated)

Added to Collection on: 2024-05-08 00:19:54

Tags for this article:

Biotechnology
NK-92
Bempegaldesleukin
Therapy
Cell therapy
Natural killer cell
Regenerative Medicine Advanced Therapy
Atlas Venture

Click the tags to see associated articles and topics

View Article Details
Book a Demo